About a decade ago, the front office of the Philadelphia 76ers attempted a radically new way of running a professional basketball team, bringing the “moneyball” approach to the game. Zavain Dar — an investor at Lux Capital — took on an advisor side gig using his love of basketball and data. The “Trust the Process” mantra turned the team into contenders.
Dar, 35, is now betting a similar story will play out in the drug industry with data and AI. He left Lux to start his own fund, Dimension, in 2022 alongside Nan Li and Adam Goulburn. The trio raised $350 million for its first fund to invest in the convergence of tech and biotech.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.